adenosine has been researched along with Erythroderma, Sezary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagot, M; Bensussan, A; Bozonnat, A; de Masson, A; Dumont, M; Marie-Cardine, A; Ram-Wolff, C; Sonigo, G; Thonnart, N | 1 |
| Bracci, C; Fia, M; Funaro, A; Marchisio, S; Ortolan, E; Quaglino, P; Ribero, S; Rumore, MR; Senetta, R; Tampieri, C; Yakymiv, Y | 1 |
| Jones, CL; Whittaker, S | 1 |
| Coleman, MS; Hutton, JJ; Koller, CA; Mitchell, BS; Siaw, MF | 1 |
| Blanc, CM; Cataldo, F; Derossi, G; Ho, AD; Kuse, R; Lauria, F; McVie, G; Stryckmans, P; Thaler, J; Willemze, R | 1 |
1 trial(s) available for adenosine and Erythroderma, Sezary
| Article | Year |
|---|---|
Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Antineoplastic Agents; Coformycin; DNA, Neoplasm; Drug Evaluation; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Multicenter Studies as Topic; Neoplasm Proteins; Pentostatin; Ribonucleosides; Sezary Syndrome | 1989 |
4 other study(ies) available for adenosine and Erythroderma, Sezary
| Article | Year |
|---|---|
Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome.
Topics: 5'-Nucleotidase; Adenosine; Antibody-Dependent Cell Cytotoxicity; Antigens, CD; Apyrase; Cell Proliferation; Humans; Killer Cells, Natural; Sezary Syndrome; Skin Neoplasms | 2022 |
CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sézary syndrome.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Apyrase; Humans; Immune Tolerance; Immunosuppression Therapy; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2023 |
CD39-CD73-adenosine effects in Sézary syndrome.
Topics: Adenosine; Adenosine Triphosphate; Humans; Immunosuppression Therapy; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2023 |
ATP depletion as a consequence of adenosine deaminase inhibition in man.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Aged; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Erythrocytes; Humans; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Sezary Syndrome | 1980 |